Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",18539,153,0.98 [0.75-1.29],0.8972230606532672
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19487,201,1.09 [0.88-1.34],0.4462608797431772
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19265,1408,1.03 [0.95-1.12],0.4660420695390056
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Candidiasis,19504,446,0.95 [0.81-1.12],0.5275869876450221
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,18860,3448,1.04 [0.99-1.10],0.1411816610809941
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),18844,3494,1.06 [1.01-1.12],0.0267497458998879
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19259,1150,0.99 [0.90-1.09],0.8336757260696039
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19417,108,1.14 [0.88-1.49],0.3211419157018045
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17206,1018,1.02 [0.92-1.13],0.7329159977293662
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16578,1231,1.07 [0.98-1.17],0.1138512783837132
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,16242,269,0.89 [0.72-1.11],0.3120244117092114
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12703,2208,1.03 [0.97-1.10],0.3331432143520101
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16191,393,1.17 [1.03-1.34],0.0173776655036079
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19469,1360,0.99 [0.91-1.08],0.8448072231220934
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Mycoses,19575,517,1.02 [0.89-1.17],0.7727985180241201
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18852,995,1.04 [0.94-1.15],0.4553246232188968
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19516,1130,1.03 [0.94-1.13],0.5372558965715712
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18310,201,1.08 [0.88-1.34],0.4541918980186181
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19624,50,0.93 [0.57-1.51],0.7782927538397505
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19368,982,1.02 [0.92-1.13],0.6788573849834476
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19371,62,1.08 [0.73-1.59],0.7009480099880168
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19567,110,1.09 [0.82-1.45],0.556598564526936
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19553,96,1.05 [0.76-1.45],0.7682962749567239
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18235,378,1.03 [0.87-1.21],0.7577619680799642
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18107,250,1.01 [0.82-1.23],0.949110770133668
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18208,99,1.04 [0.76-1.41],0.8187197261675858
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19610,45,0.95 [0.58-1.58],0.8518225624334347
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19564,152,1.13 [0.90-1.41],0.3055906586825331
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Viral warts,19461,49,1.28 [0.93-1.75],0.1249779169878505
C2orf69,UPF0565 protein C2orf69,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19484,72,0.97 [0.66-1.45],0.8952772709018666
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm,19378,224,0.72 [0.54-0.94],0.0165923225418691
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19551,37,0.99 [0.58-1.69],0.9719470338627576
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19537,41,0.97 [0.58-1.63],0.9105722246168798
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,9282,69,0.53 [0.31-0.92],0.0237095004825171
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19239,1410,1.07 [0.99-1.16],0.1089514771549397
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of meninges,19610,54,1.17 [0.80-1.71],0.4314328786453443
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19543,67,1.36 [1.06-1.74],0.0141121680247792
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19603,92,1.36 [1.10-1.70],0.0055665973922743
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm of ovary,10292,63,0.81 [0.50-1.30],0.386746409732057
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19589,377,0.99 [0.83-1.17],0.8719725712497512
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Caecum,19603,322,1.15 [0.99-1.34],0.0742491922042863
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19500,74,1.34 [1.05-1.70],0.0170385307571936
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Descending colon,19588,221,0.94 [0.74-1.19],0.5945594896031631
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Rectum,19546,344,0.91 [0.75-1.10],0.3382879356083074
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19494,591,1.02 [0.89-1.16],0.7790749595970471
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19583,451,1.17 [1.02-1.32],0.0195701654415462
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Carcinoma in situ of breast,7742,44,0.87 [0.49-1.52],0.6149095299650271
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",7775,54,0.83 [0.50-1.40],0.4860128301370229
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",14064,63,1.02 [0.68-1.55],0.9103626431170838
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",14083,82,0.66 [0.41-1.05],0.0785137857963463
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19572,108,0.89 [0.63-1.27],0.5305270588360542
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Haemangioma, any site",19573,105,0.88 [0.61-1.26],0.4758595601303554
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Leiomyoma of uterus,10056,144,0.99 [0.74-1.30],0.920269562590454
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lung cancer and mesothelioma,12515,424,1.09 [0.94-1.26],0.2516181802760044
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Lymphoid leukaemia,14065,64,1.07 [0.72-1.58],0.7497023834392804
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",14188,187,1.30 [1.11-1.53],0.001232490773873
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",14258,257,0.93 [0.74-1.15],0.4945027700760591
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",7852,92,0.76 [0.50-1.16],0.2074996912653488
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",14096,95,1.05 [0.76-1.45],0.7582481109243326
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",14121,120,0.84 [0.59-1.19],0.3206274962741068
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",14110,109,1.15 [0.89-1.49],0.276416989270418
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",7841,81,0.88 [0.59-1.33],0.5464133093487367
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",14108,107,1.12 [0.84-1.48],0.4370662164528028
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",7040,799,0.90 [0.79-1.03],0.1177065652828172
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",14110,109,1.01 [0.74-1.38],0.9520885445452836
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",14078,77,1.13 [0.83-1.54],0.4238541935707668
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,14119,118,1.19 [0.94-1.51],0.1408778275295154
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi,19500,155,1.04 [0.81-1.34],0.7529022931469216
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanocytic naevi of trunk,19600,66,1.08 [0.74-1.56],0.6996953159144166
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Melanoma in situ,14048,97,1.21 [0.95-1.56],0.1282393682901065
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",14103,102,0.75 [0.51-1.12],0.163076868560434
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",14167,166,0.96 [0.73-1.25],0.7412675703002356
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",14296,295,0.95 [0.79-1.15],0.6123252780948697
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",14108,107,1.07 [0.79-1.44],0.6697476894072202
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,Other benign neoplasms of skin,19477,146,1.30 [1.09-1.56],0.0045186422909433
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15250,1249,1.03 [0.94-1.13],0.5719011413728237
C2orf69,UPF0565 protein C2orf69,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15317,1316,1.04 [0.96-1.14],0.3371816925486655
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19375,319,0.92 [0.75-1.12],0.4047407202340977
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,17725,107,0.71 [0.48-1.05],0.0882119564851984
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19117,61,1.36 [1.04-1.77],0.0253197491133277
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19027,2872,1.06 [1.00-1.12],0.0481691537073291
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18235,57,1.16 [0.83-1.63],0.3795090847240674
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19242,57,1.26 [0.93-1.71],0.1364812409428562
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19231,1613,1.01 [0.93-1.09],0.8204329448888265
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19229,1611,1.01 [0.93-1.09],0.8181867409759431
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,17711,93,1.18 [0.91-1.54],0.203620248718341
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19328,1150,1.11 [1.02-1.21],0.0127004835451545
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19285,100,1.10 [0.82-1.48],0.5239095636217856
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19111,55,1.33 [0.99-1.79],0.0577567316348937
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19124,68,0.81 [0.51-1.29],0.383093089809069
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19470,285,0.91 [0.74-1.13],0.3891050766710482
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19519,33,0.84 [0.43-1.62],0.5996072229618488
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19419,234,0.88 [0.69-1.12],0.3058906033856119
C2orf69,UPF0565 protein C2orf69,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18290,112,0.84 [0.59-1.19],0.3267381002882125
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,13266,329,1.16 [1.00-1.35],0.0517983564523014
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18367,85,1.21 [0.93-1.57],0.1533769920180656
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18375,93,1.25 [0.97-1.61],0.0784600840448218
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,12998,61,0.90 [0.57-1.43],0.660983626029378
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18272,44,0.88 [0.52-1.51],0.6464643895418656
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,17644,260,0.90 [0.72-1.12],0.3407064188155362
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",18986,744,1.01 [0.90-1.14],0.8432369349731399
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,18644,402,0.90 [0.75-1.07],0.2311286552072526
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,18391,149,0.97 [0.73-1.28],0.8120100406157446
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19398,1170,1.05 [0.95-1.15],0.337921073765819
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,16609,1140,1.06 [0.97-1.16],0.2203122816416229
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",13005,68,0.70 [0.42-1.16],0.1672285124997756
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",17741,84,0.98 [0.67-1.43],0.9142895268723754
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,13228,291,1.17 [0.99-1.37],0.0654803361481874
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,12985,48,1.22 [0.85-1.76],0.2878873765240172
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,16770,3833,1.06 [1.01-1.11],0.0210194284294527
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,13167,230,0.93 [0.73-1.18],0.5324857049346079
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,13522,585,1.06 [0.93-1.21],0.3556021951839941
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19578,300,1.13 [0.96-1.33],0.1515249672193428
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19401,123,1.25 [1.00-1.57],0.051704001895542
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,13065,128,1.11 [0.85-1.44],0.4427868125046648
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",13006,69,1.33 [1.02-1.73],0.0326468375153632
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19091,1434,1.05 [0.97-1.15],0.2111468814422532
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,13242,305,1.17 [1.01-1.36],0.036275460353892
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,13260,323,1.05 [0.88-1.26],0.5573538398535095
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",13649,712,1.11 [0.99-1.24],0.0691177951291923
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,13063,126,0.94 [0.69-1.29],0.6940745783357078
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19395,117,1.25 [0.99-1.57],0.061451851292993
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,13686,749,1.08 [0.97-1.20],0.1627215669550108
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,13482,545,1.08 [0.96-1.23],0.2040261040260587
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,17443,59,1.23 [0.88-1.73],0.2244645878548144
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18320,5383,1.05 [1.01-1.09],0.0270387021338756
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,17706,49,0.97 [0.59-1.59],0.8939447636667522
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,17700,43,1.29 [0.88-1.90],0.1862291794346555
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19477,1565,0.93 [0.85-1.02],0.1223983152001322
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19475,1563,0.93 [0.85-1.01],0.0951190188283856
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,17712,55,1.14 [0.77-1.69],0.5185752102869841
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19329,960,1.09 [0.99-1.20],0.065533386003694
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14771,1834,1.07 [0.99-1.14],0.0701510304122887
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19614,238,1.02 [0.83-1.25],0.8627515933790091
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,18334,92,1.02 [0.73-1.43],0.9182196944090544
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,18468,99,1.17 [0.89-1.53],0.2551652680507821
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,18512,143,1.00 [0.76-1.32],0.99418069695125
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",13098,161,1.27 [1.05-1.55],0.0161179275935406
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17277,157,1.04 [0.82-1.33],0.7522436317089596
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2095,81,0.97 [0.64-1.47],0.8810899635443876
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2234,253,1.10 [0.90-1.36],0.3397394771543643
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17188,68,1.16 [0.85-1.58],0.3360295999550506
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2063,50,0.61 [0.32-1.16],0.1337979013909187
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,18933,1813,0.95 [0.87-1.03],0.1782512869835013
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,18737,495,0.82 [0.69-0.97],0.02261572824948
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,17745,361,1.17 [1.02-1.35],0.0286403962879493
C2orf69,UPF0565 protein C2orf69,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,13828,891,1.03 [0.93-1.15],0.545277524395174
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19510,261,1.03 [0.84-1.25],0.7907825006249907
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18404,224,1.20 [1.00-1.44],0.0524344428238041
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Angina pectoris,17012,1286,1.01 [0.92-1.10],0.8741317855932689
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Aortic aneurysm,18491,311,1.09 [0.91-1.30],0.3395090481238997
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18248,68,1.26 [0.93-1.70],0.1319379385869762
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18414,234,1.12 [0.92-1.36],0.2470598273079205
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,9998,2324,0.95 [0.88-1.02],0.1375981424799845
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,AV-block,15036,547,1.08 [0.94-1.23],0.2609661339711884
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19552,465,0.96 [0.82-1.13],0.6391894495169625
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiac arrest,7890,216,1.20 [0.99-1.45],0.0656309339733654
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cardiomyopathy,14662,173,1.06 [0.83-1.35],0.6649769053743442
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",14578,89,0.98 [0.68-1.41],0.9194794167954924
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19618,59,1.02 [0.68-1.53],0.9378001840734992
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Conduction disorders,15760,1271,1.05 [0.96-1.15],0.2730553711482164
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18006,2302,0.99 [0.92-1.06],0.7622396626514032
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15893,7543,1.01 [0.97-1.05],0.7315849013595974
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18324,287,1.02 [0.84-1.23],0.8501621670263104
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Endocarditis,14566,77,1.10 [0.78-1.57],0.5818791409559425
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19381,1366,1.02 [0.94-1.11],0.5936239300422075
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertension,16935,6681,1.02 [0.98-1.06],0.3027314044435346
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16939,6685,1.02 [0.98-1.06],0.2862340287666459
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19481,85,1.25 [0.98-1.61],0.0731975564655907
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",10493,239,1.12 [0.92-1.36],0.2456640531116233
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,10378,124,0.93 [0.67-1.28],0.6508685206090234
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Hypotension,19472,1302,1.08 [0.99-1.17],0.0761481556462772
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,18567,118,0.69 [0.47-1.01],0.0576208092501993
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18165,2439,0.99 [0.93-1.06],0.8042607360742315
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19210,660,1.05 [0.94-1.18],0.3982994396324075
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Left bundle-branch block,14912,423,1.06 [0.90-1.23],0.5024674282251484
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19070,875,1.04 [0.94-1.16],0.4504881705132093
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16481,755,1.09 [0.98-1.22],0.10700269589768
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19511,163,1.14 [0.92-1.40],0.2409490815373674
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19586,339,1.01 [0.85-1.21],0.8874760388997898
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Oesophageal varices,18094,57,1.10 [0.74-1.62],0.64103215421326
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other aneurysm,18266,86,1.07 [0.76-1.50],0.7027700384044244
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arrhythmias,14978,489,1.09 [0.95-1.26],0.2125242621836188
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18288,108,1.52 [1.28-1.79],1.0607812451080074e-06
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18445,265,1.09 [0.90-1.31],0.3910862578121006
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,14677,188,1.04 [0.82-1.33],0.7212040242392985
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other disorders of veins,18125,88,1.15 [0.85-1.55],0.356553844930805
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18075,38,1.13 [0.73-1.74],0.5758865746542807
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,17949,72,0.97 [0.64-1.45],0.8676268416724893
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18176,139,1.06 [0.81-1.39],0.6759779821788359
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15667,1178,1.09 [0.99-1.19],0.0770437848453352
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18220,50,1.20 [0.83-1.74],0.33063700771107
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18774,594,1.13 [1.00-1.27],0.0490125941491006
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,18985,452,1.02 [0.88-1.18],0.7979962261191414
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",18670,793,1.02 [0.92-1.15],0.67599021864952
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,8013,339,0.98 [0.82-1.18],0.8603163377902333
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18636,486,1.18 [1.04-1.33],0.0116376295281585
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18397,360,0.91 [0.76-1.10],0.3376454832670237
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19026,493,0.97 [0.83-1.13],0.6710078890147393
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19535,795,1.06 [0.95-1.18],0.2740923950685074
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Right bundle-branch block,14915,426,1.06 [0.91-1.24],0.4671565049192454
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Secondary right heart disease,18980,447,1.02 [0.88-1.19],0.7759586307715922
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18087,210,0.92 [0.72-1.18],0.508161587707134
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19194,745,1.02 [0.91-1.15],0.7276931761418834
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19181,776,1.02 [0.91-1.15],0.6846202887092234
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,18539,48,0.92 [0.55-1.53],0.7501990136718921
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18262,82,0.99 [0.69-1.44],0.9775809740856192
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Transient ischemic attack,18804,254,1.00 [0.81-1.23],0.9749133690844374
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18461,266,1.09 [0.91-1.31],0.3334228892862302
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Varicose veins,18463,426,1.12 [0.97-1.29],0.1253405662470969
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18195,99,0.95 [0.66-1.35],0.7578224439492364
C2orf69,UPF0565 protein C2orf69,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19389,784,0.93 [0.82-1.05],0.2428752050732543
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19556,279,1.10 [0.93-1.30],0.2736892560826084
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16865,1165,1.10 [1.01-1.20],0.0325476036238032
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Any mental disorder,19191,3491,1.02 [0.97-1.08],0.4635884257322953
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19533,328,1.06 [0.90-1.25],0.493884809523329
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16891,1191,1.06 [0.97-1.16],0.2261523201888239
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",15763,63,1.29 [0.97-1.72],0.0752799121976253
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Smoking dependency,19188,973,1.12 [1.02-1.22],0.015021081623012
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16908,1208,1.08 [0.99-1.18],0.0675252144790407
C2orf69,UPF0565 protein C2orf69,Chapter V Mental and behavioural disorders,Vascular dementia,18923,194,0.76 [0.57-1.01],0.054714456174719
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Alzheimer disease,19621,495,0.84 [0.71-1.00],0.0452665258689082
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",12230,89,0.79 [0.52-1.19],0.2580066266761933
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Bell's palsy,18098,70,0.67 [0.40-1.10],0.1152079247168824
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18443,415,0.94 [0.79-1.11],0.4420452728437322
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral cysts,19256,198,1.05 [0.84-1.30],0.6796479760882614
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19560,325,0.81 [0.65-1.00],0.0511864112862396
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,18937,73,0.79 [0.50-1.25],0.3063425245682536
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19605,60,0.89 [0.55-1.42],0.6155452189448002
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19124,66,0.92 [0.60-1.42],0.721580423005981
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Epilepsy,18387,247,1.05 [0.86-1.28],0.6460843642941307
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19239,1099,1.00 [0.91-1.11],0.987077299400696
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19573,537,0.90 [0.77-1.05],0.1688500162885934
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19073,2804,0.98 [0.92-1.05],0.622317124104359
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Generalized epilepsy,19318,45,1.21 [0.84-1.76],0.3018073482714521
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hemiplegia,19501,266,0.82 [0.65-1.04],0.0953791581883483
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Hydrocephalus,19118,60,1.23 [0.90-1.69],0.1918320244175464
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19610,58,0.93 [0.58-1.47],0.7525840028122094
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18088,60,0.70 [0.41-1.18],0.1827963648110285
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18087,59,0.82 [0.50-1.35],0.4281298191876579
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Memory loss,18710,128,1.06 [0.81-1.39],0.6755786512366134
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Migraine,18375,235,1.04 [0.85-1.29],0.6890018914994049
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19579,214,1.07 [0.86-1.32],0.5463787475806834
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Motor neuron disease,12327,165,1.10 [0.87-1.40],0.4076988793126077
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19515,51,0.78 [0.46-1.34],0.3729954781613431
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19032,1004,0.94 [0.84-1.05],0.2727016648520882
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Neurological diseases,18380,3467,0.96 [0.91-1.02],0.216977009867841
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19105,241,0.98 [0.79-1.21],0.8220049249438681
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18356,328,0.99 [0.82-1.19],0.8828326220859046
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19552,285,1.01 [0.84-1.22],0.911236643141376
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,14892,796,0.91 [0.80-1.03],0.121012927916954
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19125,67,0.99 [0.66-1.48],0.9440953094424692
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19190,132,0.85 [0.61-1.18],0.3242769039417013
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19214,178,0.92 [0.70-1.19],0.5175625774775535
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18105,77,0.65 [0.40-1.05],0.0783143621883974
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other headache syndromes,18184,44,0.72 [0.38-1.33],0.2933794619513578
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other neurological diseases,19527,469,1.06 [0.92-1.21],0.4542037678155529
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Other sleep disorders,18556,416,1.01 [0.86-1.19],0.9041352071454232
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Parkinson's disease,19590,339,0.89 [0.73-1.09],0.2572984585440764
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19096,38,0.87 [0.47-1.58],0.6387995418290531
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Restless leg syndrome,19620,79,0.82 [0.53-1.26],0.3688456723235599
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Sleep apnoea,19435,359,0.98 [0.81-1.17],0.7884331832608321
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19317,50,1.02 [0.65-1.60],0.924941279293956
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19609,185,1.07 [0.86-1.33],0.5592282550178591
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18087,59,0.84 [0.51-1.36],0.4732931586733369
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19621,500,0.87 [0.74-1.03],0.1029175950677375
C2orf69,UPF0565 protein C2orf69,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),18868,188,0.75 [0.56-1.00],0.0506280297911382
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19087,124,0.77 [0.54-1.09],0.1388158553992452
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19257,475,1.02 [0.88-1.19],0.7675933746891487
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19419,222,1.00 [0.80-1.24],0.9691135188513442
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,18574,58,1.01 [0.66-1.55],0.950844853628628
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,18551,35,1.39 [1.00-1.92],0.0494997591888631
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19520,60,1.09 [0.74-1.59],0.6632217700946896
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19355,191,0.92 [0.72-1.19],0.5462632588891617
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2067,53,0.57 [0.30-1.08],0.0835056992674266
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2542,92,1.01 [0.71-1.43],0.9512158138371968
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19057,94,1.23 [0.95-1.59],0.1102688662869546
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19389,1200,1.06 [0.97-1.16],0.178033074839749
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19267,751,1.10 [0.99-1.22],0.0742374626399582
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,18771,255,1.14 [0.96-1.36],0.13534851956813
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19567,785,1.03 [0.92-1.15],0.6400115708072194
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19615,67,1.30 [1.00-1.69],0.0513865706983192
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19515,733,1.03 [0.92-1.16],0.6021327017103528
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19587,423,1.01 [0.86-1.18],0.892881543195688
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19520,186,1.26 [1.06-1.51],0.0085291141029947
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,18603,87,1.11 [0.82-1.51],0.4903545369102233
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,18603,87,1.04 [0.75-1.43],0.8231636462400688
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,18583,67,1.17 [0.84-1.62],0.3590100615291564
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19504,848,0.98 [0.88-1.10],0.7753392839405949
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,18883,227,0.83 [0.64-1.07],0.1444565008048753
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,18840,58,0.62 [0.35-1.09],0.0957876027065788
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19271,107,1.05 [0.78-1.42],0.7489443818354552
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19493,329,0.99 [0.82-1.19],0.8848301057851737
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,18963,181,1.18 [0.97-1.44],0.0885386842860812
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19449,115,1.11 [0.85-1.46],0.4437043059825274
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19210,554,1.03 [0.90-1.18],0.6712422228069896
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19098,135,0.99 [0.75-1.32],0.9652349181171332
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17563,2735,1.04 [0.98-1.10],0.2329429756280181
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19456,292,1.02 [0.85-1.23],0.8251955830909963
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19606,156,1.14 [0.91-1.43],0.2564175399451027
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,18980,464,1.11 [0.97-1.26],0.1344627872425577
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19245,81,1.01 [0.71-1.45],0.954359360689218
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19607,59,1.33 [1.02-1.74],0.0324419085739746
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,18624,108,1.01 [0.74-1.38],0.9449685562366426
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,18669,153,1.18 [0.96-1.46],0.1204897650755269
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,18326,137,1.18 [0.95-1.48],0.1338910935435066
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,18829,47,0.85 [0.49-1.47],0.5598020014419804
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18253,64,0.75 [0.46-1.23],0.2565587062499507
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,18753,97,1.07 [0.78-1.45],0.6854563888102565
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",18902,246,0.88 [0.70-1.11],0.2796420512100545
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,18647,131,1.17 [0.93-1.48],0.1804518879107827
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,18266,77,1.07 [0.76-1.52],0.6898847265706083
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,18292,103,0.88 [0.61-1.26],0.4939171237908272
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17103,2275,0.98 [0.92-1.05],0.6336793921745681
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,18594,78,0.99 [0.68-1.44],0.9382555626704034
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19385,422,1.02 [0.88-1.19],0.7717286056859249
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19029,66,1.13 [0.81-1.58],0.4578634322238596
C2orf69,UPF0565 protein C2orf69,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19122,159,0.95 [0.73-1.25],0.7327073103540264
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19428,94,0.87 [0.59-1.27],0.4630970591627227
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19586,119,0.87 [0.62-1.21],0.4088134808667069
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19512,94,1.19 [0.91-1.55],0.193944216538602
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19391,57,0.83 [0.50-1.37],0.4634822730078647
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19395,61,0.94 [0.60-1.47],0.7736611535667186
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19529,1004,1.03 [0.93-1.14],0.5481037671573248
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19286,761,1.04 [0.92-1.16],0.5462240978814962
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,18648,123,0.75 [0.52-1.08],0.1215771103499696
C2orf69,UPF0565 protein C2orf69,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,18600,75,1.40 [1.13-1.75],0.0022811126628573
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute pharyngitis,19452,48,0.74 [0.41-1.32],0.3043064458069077
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19555,151,0.85 [0.63-1.16],0.3072516650082522
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19456,52,0.76 [0.44-1.31],0.3178641151298925
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza,17417,126,1.03 [0.78-1.36],0.8366953809496298
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),17414,123,1.05 [0.80-1.38],0.7259810328941285
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic asthma (mode),12176,85,1.16 [0.85-1.58],0.344033681225991
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Allergic rhinitis,19540,202,1.09 [0.88-1.34],0.4260991111707819
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13254,1480,1.11 [1.03-1.20],0.0072977499953624
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13553,1462,1.11 [1.03-1.20],0.0081531769360538
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19180,150,1.14 [0.91-1.42],0.2593390807658809
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",17376,85,1.08 [0.78-1.49],0.6605755144311971
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Bronchiectasis,16425,432,1.05 [0.90-1.23],0.5145883735487066
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",16055,62,1.19 [0.84-1.68],0.3347060584848979
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,18668,2675,1.08 [1.02-1.14],0.0110030421051289
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18578,65,0.85 [0.53-1.35],0.4800752958662243
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Chronic sinusitis,18626,113,0.87 [0.61-1.23],0.425452469693367
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19375,1352,1.04 [0.96-1.14],0.3137948158765121
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Deviated nasal septum,18584,71,0.96 [0.64-1.44],0.8318818074358758
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,17798,5101,1.04 [1.00-1.09],0.0791483306820369
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18806,293,1.03 [0.85-1.24],0.7746626603525291
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Early onset COPD,18121,98,1.21 [0.92-1.58],0.1697675271367806
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Emphysema,16360,367,1.10 [0.94-1.29],0.2147959007578844
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18492,403,1.03 [0.88-1.20],0.7209217382565378
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19392,2101,1.03 [0.96-1.10],0.4664828276492891
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Interstitial lung disease,18527,438,1.05 [0.90-1.21],0.5488596210387968
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Later onset COPD,19170,1254,1.03 [0.94-1.13],0.4990938486130695
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19605,378,1.04 [0.88-1.21],0.6637468555471535
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Nasal polyp,18598,85,0.85 [0.56-1.27],0.4250155443545074
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19379,1051,0.98 [0.88-1.08],0.6760170980937349
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of pleura,19375,2227,1.05 [0.98-1.12],0.1373432636650244
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19159,646,1.04 [0.92-1.18],0.4896401772687261
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other pleural conditions,17203,55,0.81 [0.48-1.36],0.4228436249827739
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19508,513,1.05 [0.92-1.20],0.4504158409450136
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19507,1434,1.09 [1.01-1.18],0.0324152655345075
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural effusion,18251,1103,1.03 [0.94-1.13],0.5268820254305818
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pleural plaque,17369,221,0.98 [0.78-1.22],0.8586552461727981
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19155,1864,1.03 [0.96-1.11],0.4398287656567533
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19512,285,1.07 [0.90-1.28],0.4427562892965508
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pneumothorax,17296,148,1.08 [0.85-1.38],0.517538381716073
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pollen allergy,19612,172,1.14 [0.92-1.41],0.2263254871136136
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Pulmonary oedema,19069,74,1.03 [0.72-1.47],0.8698737904000264
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Respiratory insufficiency,12150,59,1.09 [0.73-1.62],0.6840592104290717
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19363,1035,0.98 [0.88-1.08],0.6743135292228399
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18716,203,1.09 [0.88-1.34],0.417438193238851
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Viral pneumonia,17532,241,1.00 [0.81-1.24],0.9765767828486056
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19192,193,1.00 [0.79-1.26],0.9811745129650294
C2orf69,UPF0565 protein C2orf69,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,6329,101,1.15 [0.84-1.57],0.3846379850003069
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,12552,52,1.03 [0.66-1.62],0.8799865462939297
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute appendicitis,19519,108,0.89 [0.63-1.26],0.5015593272165864
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute gastritis,13718,83,1.13 [0.83-1.54],0.4325170772904625
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute pancreatitis,17933,164,1.01 [0.79-1.30],0.9115312358492966
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Acute peritonitis,19222,91,1.28 [1.01-1.62],0.0450350230694519
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Alcoholic liver disease,18800,49,1.06 [0.70-1.63],0.7747983872706578
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Barrett oesophagus,14051,416,0.92 [0.77-1.09],0.3301039738267641
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",17890,121,1.17 [0.92-1.49],0.1884346534399373
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19277,121,1.17 [0.93-1.49],0.1861357730345809
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholecystitis,17948,179,1.13 [0.92-1.39],0.2524417741226223
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Cholelithiasis,18655,886,0.99 [0.89-1.11],0.8602989844586951
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic gastritis,13930,295,0.95 [0.78-1.16],0.641696943419372
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Chronic pancreatitis,17815,46,0.69 [0.38-1.27],0.2371307912791771
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19505,109,0.94 [0.67-1.31],0.7170612950652293
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Coeliac disease,18179,104,1.46 [1.22-1.74],2.895665523234963e-05
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Collagenous colitis,18154,88,0.89 [0.60-1.31],0.5565779823265579
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19523,141,0.90 [0.67-1.22],0.5090267172838936
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Constipation,19382,1731,1.03 [0.95-1.11],0.4778691954020035
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn disease,18132,66,1.05 [0.72-1.54],0.8005239098467634
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19331,52,1.07 [0.71-1.62],0.7506190065006317
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18127,61,1.06 [0.72-1.58],0.7562868265232164
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Dental caries,19097,156,1.06 [0.83-1.36],0.6478665445203458
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16994,2148,1.03 [0.96-1.10],0.3730578416615966
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of appendix,19544,133,0.88 [0.64-1.20],0.4123637446697179
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of liver,19524,773,1.07 [0.96-1.20],0.2062492469077896
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",17482,3847,1.04 [0.99-1.10],0.1175708796037848
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19338,397,1.06 [0.90-1.23],0.4927922906057397
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19549,418,1.00 [0.85-1.18],0.9741352655937572
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19016,75,0.72 [0.45-1.15],0.1654055090497148
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of salivary glands,18914,44,1.18 [0.79-1.77],0.4081350781792365
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19353,1278,1.01 [0.92-1.10],0.8410098507790058
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diseases of tongue,18925,77,1.00 [0.69-1.45],0.9817518631857056
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19041,1272,1.03 [0.95-1.13],0.4472286298576098
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,15697,3197,1.00 [0.95-1.06],0.8832073723304563
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Duodenal ulcer,13837,202,1.13 [0.93-1.38],0.2140843539839464
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19532,161,1.20 [0.98-1.47],0.0764348255902857
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19594,18,0.73 [0.28-1.91],0.5187541989590316
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,18878,127,0.98 [0.73-1.32],0.8989140465246317
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,12595,95,1.07 [0.78-1.47],0.6860378798027473
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Functional dyspepsia,14108,473,1.09 [0.95-1.26],0.1981645053418448
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastric ulcer,13992,357,1.06 [0.90-1.24],0.4954281625919539
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15858,2223,1.04 [0.97-1.11],0.3086504559353618
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,14179,544,1.12 [1.00-1.27],0.0594140034239669
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,14254,6944,1.04 [1.00-1.08],0.0597601176268797
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,GI-bleeding,19122,1047,0.94 [0.84-1.04],0.2426616040039861
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,18985,44,0.96 [0.56-1.62],0.8656467961182499
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,13346,1010,0.96 [0.86-1.06],0.4035014975249504
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",18809,58,1.09 [0.75-1.58],0.651292108965212
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Hernia,17890,3044,1.04 [0.98-1.10],0.1980150414164094
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impacted teeth,19596,17,0.88 [0.36-2.16],0.7806324464788701
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Impaction of intestines,12565,65,1.20 [0.88-1.65],0.2522789311517784
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Inguinal hernia,15760,914,1.01 [0.91-1.13],0.7964477834628582
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",14945,99,0.98 [0.70-1.37],0.9109702224985106
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,12595,95,0.82 [0.56-1.21],0.3266100204895697
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18198,123,1.38 [1.15-1.65],0.0006305506319069
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,12928,428,0.91 [0.77-1.08],0.2719799497430477
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19601,278,1.15 [0.97-1.36],0.0987381006564749
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,18721,655,1.17 [1.06-1.30],0.0027035433986614
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,18985,919,1.10 [1.00-1.21],0.0489158303030101
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophageal obstruction,13813,178,0.95 [0.74-1.23],0.6968614045214212
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oesophagitis,14221,586,0.91 [0.78-1.05],0.205689716087113
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19573,113,0.88 [0.62-1.24],0.4481576469471467
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,14916,70,1.21 [0.89-1.65],0.2210056380334719
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,13658,1158,1.06 [0.97-1.16],0.2119003553005451
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18065,296,0.97 [0.80-1.17],0.7295251056685195
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,17892,123,1.01 [0.76-1.36],0.927503726249924
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestine,14135,1635,1.06 [0.98-1.14],0.1385562017842317
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of intestines,17681,5181,1.00 [0.96-1.05],0.8714932520955322
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,18898,181,1.04 [0.82-1.31],0.7735162275215691
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of liver,19388,637,1.07 [0.94-1.20],0.2981010558663965
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,14271,636,1.01 [0.89-1.15],0.8488671030184813
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of pancreas,17938,169,0.97 [0.75-1.26],0.8240025327516626
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19485,354,0.93 [0.77-1.12],0.460443031113205
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,14551,916,1.05 [0.95-1.16],0.338332787851113
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19134,1059,0.94 [0.84-1.04],0.2437267853924246
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19088,147,1.14 [0.90-1.43],0.2695018044717867
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,14269,1769,1.01 [0.94-1.09],0.763784666407429
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15465,1830,1.03 [0.95-1.11],0.4888987737716541
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,18849,98,1.20 [0.92-1.57],0.1784643865088299
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,18880,814,1.11 [1.01-1.23],0.0370366045014837
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",12869,369,0.95 [0.79-1.13],0.5529278986282775
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19591,22,0.88 [0.40-1.93],0.7461642828864025
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13017,517,0.99 [0.86-1.14],0.8864554000869237
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18215,140,1.15 [0.92-1.45],0.2233522928379591
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19610,44,0.50 [0.25-0.99],0.0479997536244303
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,18933,84,0.91 [0.61-1.34],0.6212876151462416
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Toxic colitis,18139,73,0.99 [0.67-1.46],0.9584725933880326
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,13929,294,0.96 [0.79-1.17],0.7164999081350462
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ulcerative colitis,18206,140,1.01 [0.77-1.34],0.9357854285962628
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18179,113,0.94 [0.68-1.31],0.7302873433978625
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Umbilical hernia,15061,215,0.85 [0.66-1.11],0.2293086515604563
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,12705,205,0.97 [0.77-1.22],0.7787913033271598
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Ventral hernia,15075,229,1.10 [0.91-1.34],0.3247356883699244
C2orf69,UPF0565 protein C2orf69,Chapter XI Diseases of the digestive system,Volvulus,12577,77,1.22 [0.92-1.62],0.158248708400753
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19532,352,1.16 [1.01-1.34],0.0375939565820078
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19315,62,0.97 [0.63-1.50],0.9037912980065632
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,17507,142,0.98 [0.74-1.30],0.8940288229635578
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19093,691,1.02 [0.90-1.15],0.7581280337073715
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18520,118,1.23 [0.98-1.56],0.0750789765092562
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,17858,493,1.05 [0.91-1.21],0.4858836276104252
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19323,262,1.01 [0.83-1.23],0.9225506043476888
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19527,466,1.00 [0.86-1.16],0.977884699563728
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19104,43,1.18 [0.78-1.77],0.4301950450267432
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18276,3134,1.00 [0.94-1.06],0.9376772175704214
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19262,364,0.98 [0.82-1.17],0.8348890157523822
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19148,250,0.98 [0.79-1.21],0.8450566764978855
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19295,893,1.06 [0.96-1.18],0.2635257811550173
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19605,49,1.18 [0.80-1.76],0.4022744349935695
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,17421,56,1.11 [0.74-1.67],0.6136245145401296
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,18952,54,1.17 [0.82-1.67],0.3898145080329259
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19311,250,1.01 [0.83-1.24],0.8941703266653017
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,17877,512,0.97 [0.83-1.13],0.6640990068114454
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,17443,78,0.69 [0.43-1.10],0.1198970121247233
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19550,71,0.72 [0.44-1.17],0.1803407238299553
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18580,178,1.12 [0.90-1.40],0.2960409284469221
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19448,195,0.86 [0.66-1.13],0.2778650101707507
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19137,76,0.99 [0.68-1.43],0.9392141197891228
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,17428,63,0.98 [0.64-1.50],0.938008730027307
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19105,1740,1.01 [0.93-1.09],0.8163288262986869
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",17915,550,1.00 [0.86-1.15],0.9705451667697236
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,17446,81,0.66 [0.42-1.06],0.0846335321016468
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19544,291,0.96 [0.79-1.18],0.7104247971404124
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19127,66,0.88 [0.56-1.38],0.56641581862588
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19494,241,0.91 [0.73-1.15],0.4373777972375609
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19561,381,1.13 [0.97-1.30],0.1068662722459367
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,17471,106,1.10 [0.82-1.47],0.5133464094803584
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,17645,280,0.86 [0.69-1.07],0.1834354019132527
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19549,369,1.12 [0.97-1.30],0.1227841308404045
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",17631,266,1.16 [0.98-1.38],0.0882274924191373
C2orf69,UPF0565 protein C2orf69,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19598,119,0.96 [0.70-1.31],0.776859848556962
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,16385,69,1.22 [0.89-1.67],0.2261754936539048
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,17316,5417,1.04 [0.99-1.08],0.101360637561346
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,16137,4238,1.04 [0.99-1.09],0.0931037408197156
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,16361,45,0.77 [0.43-1.39],0.3891778355534653
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,16349,118,1.08 [0.82-1.42],0.591757217463797
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,16384,153,0.88 [0.65-1.18],0.3916752650725628
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19407,51,1.24 [0.88-1.76],0.2250005845208524
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",16355,124,0.89 [0.65-1.22],0.4786483094234517
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,13152,1253,1.04 [0.95-1.13],0.4129579618965134
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19441,211,1.07 [0.87-1.32],0.5183571840674563
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,16698,467,1.02 [0.87-1.18],0.8309848462661162
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,15900,6771,1.04 [1.00-1.09],0.0280195852403416
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,17517,106,0.93 [0.66-1.31],0.6675632107376652
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,16466,150,0.97 [0.74-1.28],0.841695960483786
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,16743,427,1.01 [0.86-1.19],0.8717928765276926
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18820,2589,1.01 [0.95-1.08],0.7262089678960998
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,16578,262,0.85 [0.67-1.07],0.1621857912707464
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,16437,121,1.16 [0.89-1.51],0.2626912233356277
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,16414,98,0.74 [0.49-1.11],0.1415210169223495
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,18960,87,1.08 [0.78-1.50],0.636706773863501
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,13606,1707,1.01 [0.94-1.10],0.7556529574146419
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,12535,636,1.06 [0.94-1.20],0.3078836924748022
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19537,630,1.06 [0.94-1.20],0.3725308552302414
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,11958,59,0.59 [0.33-1.03],0.0634480776119369
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),12159,260,0.79 [0.62-1.01],0.0566611873130147
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,16539,223,0.96 [0.76-1.21],0.7399144796527373
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,12315,416,1.10 [0.96-1.27],0.1799334388349822
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,16296,65,1.10 [0.78-1.57],0.5849402232973112
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,16791,560,1.04 [0.91-1.19],0.5506014783323459
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,16481,250,1.00 [0.81-1.24],0.9844538992774096
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,12288,389,1.09 [0.94-1.27],0.2507693755842392
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,16377,61,1.03 [0.68-1.55],0.9045838236592494
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",16362,46,1.05 [0.66-1.68],0.8314541640533214
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,17477,66,1.12 [0.79-1.60],0.5278531914833444
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19260,1849,1.04 [0.97-1.12],0.2730510774863609
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,18714,1303,1.03 [0.94-1.12],0.5505870002898834
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19481,459,1.06 [0.92-1.22],0.43369107253578
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14541,2642,1.06 [1.00-1.13],0.0426792031448951
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,11937,38,0.76 [0.39-1.45],0.3979408481177606
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,16401,85,1.08 [0.77-1.51],0.6611447579310592
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,11962,63,1.12 [0.80-1.58],0.5023162211879755
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),12015,116,1.04 [0.78-1.39],0.7959292690871783
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,17612,201,1.06 [0.85-1.32],0.6010193119258767
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,17816,405,1.01 [0.86-1.19],0.8833085328351364
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19605,88,1.31 [1.03-1.66],0.0270440197366155
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17863,1632,1.00 [0.93-1.09],0.9253507203735926
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,16375,59,1.27 [0.92-1.77],0.1519137169456234
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),12026,127,0.87 [0.63-1.21],0.4124566594629921
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,16886,655,0.99 [0.87-1.13],0.9185339010217566
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,13728,1829,0.98 [0.91-1.06],0.6406401589199752
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,18981,108,1.13 [0.86-1.49],0.3859272665450673
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19614,59,1.00 [0.65-1.54],0.9818548489128044
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,16383,67,0.94 [0.61-1.45],0.791197273517366
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17435,1119,1.06 [0.96-1.16],0.2524691157979666
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,16403,87,1.12 [0.81-1.53],0.4994092794350226
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,13645,1746,1.02 [0.95-1.10],0.5718121185169919
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,17511,100,0.99 [0.70-1.39],0.9395928821436
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,16342,26,0.95 [0.48-1.87],0.8751307590683867
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,16394,163,0.84 [0.63-1.13],0.2537993237285183
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,16883,567,1.04 [0.91-1.19],0.6003566360841462
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19295,422,1.16 [1.01-1.33],0.0321585621895403
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,16768,537,0.87 [0.75-1.02],0.0974343904211281
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19493,455,1.06 [0.91-1.22],0.4638303484851654
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19599,56,1.00 [0.65-1.54],0.996313895082772
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,16453,137,0.98 [0.73-1.30],0.8774586386724046
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,15290,717,1.03 [0.91-1.16],0.6651561038273823
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,16847,531,1.04 [0.91-1.20],0.5414572735139436
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],16551,235,0.89 [0.70-1.13],0.3304137432629541
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",11962,63,1.24 [0.91-1.68],0.1698858540287977
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14515,2616,1.04 [0.98-1.10],0.2304854586896489
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,12598,699,1.00 [0.89-1.13],0.978734831501619
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19185,312,1.03 [0.86-1.23],0.7662502483360102
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19578,61,1.12 [0.77-1.63],0.5578941593792535
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",17368,57,0.96 [0.61-1.52],0.8638885883165974
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,11959,60,0.99 [0.64-1.53],0.9688372461095768
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,16322,91,1.13 [0.83-1.52],0.4410859443498374
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,12364,465,1.07 [0.93-1.23],0.369704784381679
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,16600,284,1.11 [0.93-1.32],0.2546025173310018
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,16466,235,1.27 [1.09-1.48],0.0027588705017557
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,16449,218,1.09 [0.89-1.34],0.414989141201458
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,13821,59,1.00 [0.65-1.55],0.9865370049927006
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19603,60,0.91 [0.58-1.44],0.6979142339910492
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,16785,469,1.11 [0.97-1.27],0.1419555175921859
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],18961,88,1.51 [1.23-1.86],6.778813488946878e-05
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,18519,2203,1.04 [0.97-1.11],0.3098612265083026
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",16440,124,0.96 [0.70-1.30],0.7879236379294318
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,16797,566,1.06 [0.93-1.21],0.3897261946876718
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,18443,222,0.81 [0.62-1.04],0.1029120103836623
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,16427,196,1.00 [0.79-1.27],0.9948940658550636
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17855,1624,1.01 [0.94-1.10],0.7432896864244695
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17296,1065,1.02 [0.92-1.13],0.6798386095945619
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],16364,48,0.88 [0.52-1.51],0.6521124207024611
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,18983,110,1.15 [0.87-1.52],0.3281875948793178
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,16460,144,1.19 [0.94-1.49],0.1447891137985588
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,16395,79,0.95 [0.64-1.40],0.7868370097227028
C2orf69,UPF0565 protein C2orf69,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),11960,61,0.66 [0.38-1.12],0.122797678187332
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Acute renal failure,18503,1790,1.06 [0.98-1.14],0.1504436554843249
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),7909,22,1.30 [0.77-2.21],0.3228519856663809
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,10038,28,1.07 [0.59-1.92],0.8332714555690325
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19350,260,1.05 [0.87-1.28],0.5903107888486612
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19178,88,0.99 [0.70-1.41],0.9742691406700542
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18429,1716,0.99 [0.91-1.07],0.8323040489892111
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19439,87,0.90 [0.61-1.33],0.6040517148627258
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19402,330,0.91 [0.75-1.11],0.3673269067741523
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Cystitis,16472,255,0.95 [0.76-1.18],0.6291944757761035
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Dialysis,16782,69,0.97 [0.64-1.47],0.9027519813921272
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,8595,1774,1.01 [0.93-1.09],0.8631371920700438
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Disorders of breast,10118,108,1.08 [0.80-1.45],0.6328850456092832
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Endometriosis,7921,34,1.23 [0.77-1.97],0.3823174408388051
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,8369,482,1.11 [0.97-1.27],0.124406722151613
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,16209,5186,1.04 [0.99-1.08],0.1195629090370555
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19420,68,0.90 [0.59-1.39],0.6437267840906697
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydrocele,6923,102,1.15 [0.87-1.51],0.3321971378308279
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,16737,272,0.95 [0.77-1.17],0.6263582984907796
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,8333,1512,1.01 [0.93-1.09],0.9006406014496968
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,10174,137,1.00 [0.75-1.33],0.9868919840978524
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),6924,103,0.59 [0.38-0.91],0.0173217132066242
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,16287,70,0.95 [0.63-1.43],0.8036858769709512
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,8756,869,1.03 [0.92-1.14],0.6470066625875232
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,6871,50,0.62 [0.33-1.14],0.123934163621864
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,7920,33,0.56 [0.26-1.21],0.1415820048387193
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19615,75,0.97 [0.66-1.43],0.873001325072647
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19610,74,0.73 [0.45-1.16],0.1824322202426735
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18613,2396,0.98 [0.92-1.05],0.5717926500272983
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17004,787,1.04 [0.93-1.16],0.4631154802502045
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,10055,45,1.02 [0.63-1.65],0.9415325879673568
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19560,488,0.99 [0.86-1.15],0.9338748980508548
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,6942,121,0.93 [0.68-1.29],0.6778821510586964
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,6958,137,0.87 [0.63-1.20],0.396626179016798
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,6944,123,0.91 [0.66-1.25],0.5569996337262457
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19590,69,1.09 [0.76-1.56],0.6437071319885764
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18091,1874,0.95 [0.88-1.03],0.2447221459028136
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,10108,71,0.88 [0.57-1.36],0.5536435678908163
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,7950,63,1.40 [1.07-1.84],0.0152479668010233
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",8018,131,0.97 [0.72-1.30],0.8147823819493227
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,7935,48,1.02 [0.63-1.64],0.9453999719534534
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,7972,85,0.98 [0.68-1.41],0.8988572339626197
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,16787,322,1.04 [0.87-1.25],0.6345601315475229
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19226,154,0.91 [0.69-1.21],0.528153475807511
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,7993,106,1.20 [0.92-1.56],0.1738133986157534
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,7909,22,0.83 [0.37-1.86],0.6466874520544845
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,8070,183,1.03 [0.81-1.31],0.8276575109858884
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,7967,80,1.15 [0.84-1.58],0.3911559551719735
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,8061,174,0.87 [0.66-1.15],0.3397534111459263
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19399,47,0.67 [0.36-1.24],0.1992554369031977
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",6946,125,0.97 [0.72-1.31],0.8597348888100185
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19419,2954,1.04 [0.98-1.10],0.1930537675276658
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",16542,77,0.87 [0.57-1.33],0.5133071700924752
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,16851,138,1.18 [0.95-1.48],0.1394442864163614
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19120,30,0.67 [0.31-1.45],0.3096505449886115
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urethral stricture,16442,225,1.01 [0.81-1.26],0.9122378459281106
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19423,333,1.04 [0.87-1.23],0.6928990743389243
C2orf69,UPF0565 protein C2orf69,Chapter XIV Diseases of the genitourinary system,Uterine polyps,7920,33,1.06 [0.61-1.86],0.8344540142743042
